MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 52 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,875,708 | +76.8% | 122,649 | +44.7% | 0.00% | – |
Q2 2023 | $2,192,095 | -13.8% | 84,735 | -20.0% | 0.00% | – |
Q1 2023 | $2,542,829 | -30.4% | 105,863 | -43.5% | 0.00% | – |
Q4 2022 | $3,653,930 | +220.8% | 187,381 | +245.5% | 0.00% | – |
Q3 2022 | $1,139,000 | +509.1% | 54,242 | +464.1% | 0.00% | – |
Q2 2022 | $187,000 | +50.8% | 9,616 | +71.3% | 0.00% | – |
Q1 2022 | $124,000 | +15.9% | 5,614 | -16.3% | 0.00% | – |
Q4 2021 | $107,000 | +62.1% | 6,706 | +102.3% | 0.00% | – |
Q3 2021 | $66,000 | +40.4% | 3,315 | +21.9% | 0.00% | – |
Q2 2021 | $47,000 | -65.4% | 2,719 | -60.4% | 0.00% | – |
Q1 2021 | $136,000 | +161.5% | 6,871 | +134.7% | 0.00% | – |
Q4 2020 | $52,000 | +48.6% | 2,927 | +63.0% | 0.00% | – |
Q3 2020 | $35,000 | -36.4% | 1,796 | -35.5% | 0.00% | – |
Q2 2020 | $55,000 | -3.5% | 2,785 | -30.9% | 0.00% | – |
Q1 2020 | $57,000 | -56.8% | 4,029 | -25.2% | 0.00% | – |
Q4 2019 | $132,000 | +158.8% | 5,385 | +5.6% | 0.00% | – |
Q3 2019 | $51,000 | – | 5,101 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |